Brett GiffinCEO Fibronostics
Brett joined Fibronostics as CEO in September of 2017, after serving 2 ½ years as President & CEO of 3si Systems, an IT-based healthcare technology company. Brett has more than 30 years of executive experience in a variety of general and commercial management roles in large, medium, and small healthcare companies. He has extensive experience in P&L management, sales and marketing leadership, strategic planning, product launches, product development, and business development on a global level.
Prior to 3si Systems, Brett was the Chief Commercial Officer of Accriva Diagnostics, a Warburg Pincus portfolio company, formed in 2013 through the merger of International Technidyne Corporation (ITC) and Accumetrics. In his almost 8 years of executive leadership roles with Accriva/ITC Brett led the company through greater than market revenue growth, successfully managed the acquisition of Accumetrics, and led the global commercial integration of the ITC and Accumetrics companies. Brett played a key leadership role in the divestiture of ITC from publicly-traded Thoratec Corporation and succeeding sale of the company to Warburg Pincus in 2010.
Prior to Accriva/ITC, Brett served in leadership roles with Drager Medical as Vice President of Marketing, iDEV Technologies as National Sales Director, Vice President of Sales & Marketing at Datascope Corporation , Vice President of Marketing at Mallinckrodt Medical, International Marketing Manager at Boston Scientific, and a variety of positions in marketing and sales management over a 10-year period with Johnson & Johnson Medical.
Brett began his career as a US Army Officer, attained the final rank of Captain, and served in Panama and Latin America.
He has a B.A. degree from Christopher Newport University, is a Distinguished Military Graduate from the College of William & Mary, and holds an M.A. in Business Management from the University of Phoenix.